Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000027

Chief Medical Officer sold 22,575 shares at an average $28.91 ($652,638)

  • Chief Medical Officer acquired 16,226 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2026-05-11 Option exercise 10b5-1 +2,171 $16.00 $34,736 71,963 D
Rodman David Malcom Chief Medical Officer 2026-05-11 Sale 10b5-1 −2,171 $29.71 $64,500 69,792 D
Rodman David Malcom Chief Medical Officer 2026-05-12 Option exercise 10b5-1 +6,348 $1.08 $6,856 76,140 D
Rodman David Malcom Chief Medical Officer 2026-05-12 Sale 10b5-1 −6,348 $29.36 $186,348 69,792 D
Rodman David Malcom Chief Medical Officer 2026-05-13 Option exercise 10b5-1 +3,541 $10.20 $36,118 73,333 D
Rodman David Malcom Chief Medical Officer 2026-05-13 Option exercise 10b5-1 +4,166 $14.25 $59,366 77,499 D
Rodman David Malcom Chief Medical Officer 2026-05-13 Sale 10b5-1 −14,056 $28.58 $401,789 63,443 D
Derivatives
Rodman David Malcom Chief Medical Officer 2026-05-11 Option exercise · Stock Option 10b5-1 −2,171 19,535 D
Rodman David Malcom Chief Medical Officer 2026-05-12 Option exercise · Stock Option 10b5-1 −6,348 12,698 D
Rodman David Malcom Chief Medical Officer 2026-05-13 Option exercise · Stock Option 10b5-1 −3,541 116,876 D
Rodman David Malcom Chief Medical Officer 2026-05-13 Option exercise · Stock Option 10b5-1 −4,166 87,501 D
Open-market sales · 22,575 sh · avg $28.91 · $652,638
Loading xslF345X06/wk-form4_1778722925.xml…